I feel like I came across some similar research years ago.
It brought up a question that I'm hoping someone in this field could answer: Does it make sense to speed up cancer cell replication while providing chemo drugs?
It seems like this would result in greater discrimination between fast-replicating cells (cancer) and normal cells. In turn, this would allow faster chemo treatments, or less collateral damage.